A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0843
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer ; volume:80 ; number:6 ; day:25 ; month:10 ; year:2017 ; pages:1197-1207 ; date:12.2017
Cancer chemotherapy and pharmacology ; 80, Heft 6 (25.10.2017), 1197-1207, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Sakai, Daisuke
- Contributor
-
Chung, Hyun Cheol
Oh, Do-Youn
Park, Se Hoon
Kadowaki, Shigenori
Kim, Yeul Hong
Tsuji, Akihito
Komatsu, Yoshito
Kang, Yoon-Koo
Uenaka, Kazunori
Wijayawardana, Sameera R.
Wacheck, Volker
Wang, Xuejing
Yamamura, Ayuko
Doi, Toshihiko
SpringerLink (Online service)
- DOI
-
10.1007/s00280-017-3445-z
- URN
-
urn:nbn:de:1111-201801134375
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sakai, Daisuke
- Chung, Hyun Cheol
- Oh, Do-Youn
- Park, Se Hoon
- Kadowaki, Shigenori
- Kim, Yeul Hong
- Tsuji, Akihito
- Komatsu, Yoshito
- Kang, Yoon-Koo
- Uenaka, Kazunori
- Wijayawardana, Sameera R.
- Wacheck, Volker
- Wang, Xuejing
- Yamamura, Ayuko
- Doi, Toshihiko
- SpringerLink (Online service)
Other Objects (12)
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Short-Term Safety Evaluation of a Multi-Pressure Dial: A Prospective, Open-label, Non-randomized Study
Combined exercise and nutrition intervention for older women with spinal sarcopenia: an open-label single-arm trial
Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Short-Term Safety Evaluation of a Multi-Pressure Dial: A Prospective, Open-label, Non-randomized Study
Combined exercise and nutrition intervention for older women with spinal sarcopenia: an open-label single-arm trial
Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Short-Term Safety Evaluation of a Multi-Pressure Dial: A Prospective, Open-label, Non-randomized Study
Combined exercise and nutrition intervention for older women with spinal sarcopenia: an open-label single-arm trial
Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study